- Home
- CLDI vs UCAR Comparison
CLDI vs UCAR Comparison
Compare CLDI & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDI | UCAR |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 9.2M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CLDI | UCAR |
|---|---|---|
| Price | $1.52 | $1.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 217.9K | 32.6K |
| Earning Date | 11-13-2025 | 10-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,816,075.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 57.22 |
| 52 Week Low | $1.10 | $1.74 |
| 52 Week High | $26.04 | $9.43 |
Technical Indicators
Market Signals| Indicator | CLDI | UCAR |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 32.67 |
| Support Level | $1.38 | $1.77 |
| Resistance Level | $1.55 | $1.95 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 92.42 | 7.55 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.